Budget impact analysis of breast cancer medications: a systematic review
Crossref DOI link: https://doi.org/10.1186/s40545-022-00493-1
Published Online: 2022-12-29
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mohammadnezhad, Ghader
Sattarpour, Melika
Moradi, Najmeh https://orcid.org/0000-0003-4172-4411
Text and Data Mining valid from 2022-12-29
Version of Record valid from 2022-12-29
Article History
Received: 11 July 2022
Accepted: 15 November 2022
First Online: 29 December 2022
Declarations
:
: Not applicable.
: The authors declare that they have no competing interests.